Concept explainers
One of the major causes of sickness, death, and economic loss in the cattle industry is Mannheimia haemolytica, which causes bovine pasteurellosis, or shipping fever. Noninvasive delivery of a vaccine using transgenic plants expressing immunogens would reduce labor costs and trauma to livestock. An early step toward developing an edible vaccine is to determine whether an injected version of an antigen (usually a derivative of the pathogen) is capable of stimulating the development of antibodies in a test organism. The following table assesses the ability of a transgenic portion of a toxin (Lkt) of M. haemolytica to stimulate development of specific antibodies in rabbits.
Immunogen Injected | Antibody Production in Serum |
Lkt50*– saline extract | + |
Lkt50–column extract | + |
Mock injection | – |
Pre-injection | – |
*Lkt50 is a smaller derivative of Lkt that lacks all hydrophobic regions. + indicates at least 50 percent neutralization of toxicity of Lkt; – indicates no neutralization activity.
Source: Modified from Lee et al. 2001. Infect, and Immunity 69: 5786–5793.
(a) What general conclusion can you draw from the data?
(b) With regards to development of a usable edible vaccine, what work remains to be done?
Want to see the full answer?
Check out a sample textbook solutionChapter 19 Solutions
Study Guide and Solutions Manual for Essentials of Genetics
- In addition to boosters of existing mRNA vaccines, which of the following strategies could be considered to address decreased efficacy of mRNA vaccines against variant strains of SARS-CoV-2? 1. Administration of monoclonal antibodies 2. Biannual boosters 3. Mixing adenovirus- and mRNA-based vaccines 4. Variant-specific vaccinesarrow_forwardOne strategy for vaccine development currently under investigation is the use of pathogen-derived T cell epitopes as a component of the vaccine. For viral pathogens, implementing this strategy involves scanning the predicted amino acid sequences of the viral proteins for likely peptide epitopes that would bind to MHC class I and MHC class II molecules. In addition to the complication of MHC sequence polymorphism in the human population, another complication of this strategy for peptide epitopes that would bind to MHC class II proteins is: The importance of viral proteins containing peptides that are cleaved into 8–10 amino acid long fragments. The ability of viruses to mutate their proteins to avoid MHC anchor residue sequences. The fact that long peptides (>13 amino acids) are rapidly degraded in cells. The fact that MHC class II proteins are intrinsically stable, even in the absence of binding to a peptide. The absence of defined sequence motifs that predict peptide binding to…arrow_forwardDuring the adenoviral SARS-CoV2 vaccine development process, the plasmid encoding the Spike protein is generated. Elaborate on the steps you would follow to generate a recombinant plasmid encoding the Spike protein.arrow_forward
- Regarding the production of monoclonal antibodies, it is CORRECT to state that: * A) Hybridomas are cells generated from the fusion of myeloma cells and cells from animals challenged with the antigen of interest that have the ability to produce antibodies and limited cell proliferation. B) All hybrid cells generated from the fusion of cells from the challenged animal and cells of the myeloma lineage will have the ability to produce antibodies reactive against the antigen of interest. C) The HAT selection medium contains aminopterin, which is an efficient inhibitor of the thymidine kinase metabolic pathway, thus eliminating myeloma cells that are not fused or fused with other cells of the same kind. D) The HAT selection medium contains hypoxanthine, which is an efficient inhibitor of the nucleotide synthesis salvage pathway, thus eliminating cells from the challenged animal that are not fused or fused with other identical cells. E) Hybridomas will produce antibodies with the…arrow_forwardWith respect to recombinant vaccines, it is CORRECT to state that: * (Only one statement is correct) (a) Protein subunit vaccines are formulated with the expression vector encoding the immunogenic protein or protein fragment (b) Recombinant carrier organisms are genetically modified to contain the pathogenic protein of the organism that will be the target of the vaccine (c) Nucleic acid vaccines are formulated with DNA or RNA molecules that, once internalized by cells, will generate recombinant proteins that will trigger the immune response against the desired pathogen (d) Unlike DNA vaccines, mRNA vaccines do not need to be internalized by cells, being recognized as foreign molecules to the organism that received them. (e) Laboratory-produced phages can be used as delivery tools in DNA vaccines, which will allow the expression of immunogenic proteins to the organism that received them (f) Pseudoviral particles (VLPs) are produced in cells that receive expression vectors…arrow_forwardWhat type of vaccines are the following for COVID-19: Pfizer, Moderna, and Johnson and Johnson? How do the Pfizer and Moderna vaccine relate to the central dogma of molecular biology?arrow_forward
- Monoclonal antibodies are produced by immunizing a mouse with a particular antigen, then removing its spleen. Individual B cells producing mouse antibodies specific for the antigen are isolated from the spleen, then fused with cancer cells. Each of the resulting hybrid cells can be cloned, which means it can be cultured indefinitely in the laboratory. The resulting cell lines produce and secrete antibodies that recognize the antigen to which the mouse was immunized. These antibodies are called monoclonal antibodies. Some monoclonal antibodies are used for passive immunization. They are effective, but only in the immediate term. Antibodies that are produced by one’s own immune system can last up to about six months in the bloodstream, but those delivered in passive immunization often last for less than a week. Why the difference?arrow_forwardA government official interested in determining the number of infants affected with the human immunodeficiency virus (HIV) has approached your hospital to participate in a statewide funded study. The protocol will include the testing of all newborns for HIV, but the mothers will not be told that the test is being done, nor will they be told the results? Using the basic ethical principles (available in the resources file), defend or refute the practice. How will the findings of the proposed study be affected if the protocol is carried out?arrow_forwardPlease help me answer all parts of this question: (A)What strategy/type of vaccine would you pursue with the hopes of developing a vaccine to a new pandemic Coronavirus, attenuated virus vaccine or an inactivated virus vaccine? Compare how the two are produced, the limitations or advantages, and justify why you have picked one over the other. (B) Now, compare the above vaccines to mRNA vaccines. How are mRNA vaccines delivered? Are they better than the vaccines from part (A)?arrow_forward
- How the use of the nucleic acid vaccine gives protection against diseases like COVID-19. Please briefly explain at your own words.arrow_forwardWhat are the important differences among a recombinant liveattenuated vaccine, a vector vaccine, and a subunit vaccine?arrow_forwardDo you think majority of the filipino people are aware of the different ethical issues of Covid-19 vaccines? What are the possible reason for lack of awareness?arrow_forward
- Human Anatomy & Physiology (11th Edition)BiologyISBN:9780134580999Author:Elaine N. Marieb, Katja N. HoehnPublisher:PEARSONBiology 2eBiologyISBN:9781947172517Author:Matthew Douglas, Jung Choi, Mary Ann ClarkPublisher:OpenStaxAnatomy & PhysiologyBiologyISBN:9781259398629Author:McKinley, Michael P., O'loughlin, Valerie Dean, Bidle, Theresa StouterPublisher:Mcgraw Hill Education,
- Molecular Biology of the Cell (Sixth Edition)BiologyISBN:9780815344322Author:Bruce Alberts, Alexander D. Johnson, Julian Lewis, David Morgan, Martin Raff, Keith Roberts, Peter WalterPublisher:W. W. Norton & CompanyLaboratory Manual For Human Anatomy & PhysiologyBiologyISBN:9781260159363Author:Martin, Terry R., Prentice-craver, CynthiaPublisher:McGraw-Hill Publishing Co.Inquiry Into Life (16th Edition)BiologyISBN:9781260231700Author:Sylvia S. Mader, Michael WindelspechtPublisher:McGraw Hill Education